News
Our writer can see the appeal of this recently popular dividend stock from the FTSE 100 index. But will he buy it for his own ...
A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions about the causes of obesity and treatment goals.
A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...
A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions about the ...
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
Explore more
Tirzepatide is more effective than semaglutide for weight loss, according to a new study on GLP-1 medications ; The study was ...
Gov. Mike Braun visited Lebanon Tuesday to help break ground for the $4.5 billion Eli Lilly Medicine Foundry in Lebanon. The foundry is the first research and development site of its kind in the world ...
Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
Viking Therapeutics became famous in the biotech world last year after announcing positive phase 2 results for VK2735, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results